Live Feeds
● TRACKER Updated 5d ago · 33 sources tracked

New Trigger for Alzheimer’s Disease May Have Been Found

Researchers have identified new potential triggers and risk factors for Alzheimer's disease, including lower cardiac output in carriers of the APOE-e4 allele, the protein EPS8 which builds up during aging, and tau disrupting mitochondria in nerve cells. A blood test may also reveal Alzheimer's risk years before symptoms. These findings aim to uncover hidden disease mechanisms and establish new treatment strategies.

RSS Source map (37)

What changed

New research developments have identified lower cardiac output as a predictor of faster brain loss in Alzheimer's risk gene carriers and tau's role in disrupting mitochondria in nerve cells.

Live updates

  1. Alzheimer's Research Uncovers New Disease Triggers and Risk Factors

    Researchers have identified new potential triggers and risk factors for Alzheimer's disease, including lower cardiac output in carriers of the APOE-e4 allele, the protein EPS8 which builds up during aging, and tau disrupting mitochondria in nerve cells. A blood test may also reveal Alzheimer's risk years before symptoms. These findings aim to uncover hidden disease mechanisms and establish new treatment strategies.

    Why it matters

    Alzheimer's disease is a complex neurodegenerative disorder with no cure, and researchers are working to understand its causes and develop effective treatments. Recent studies have made progress in identifying new risk factors and potential triggers. Understanding these factors is crucial for developing early detection methods and effective treatments.

    What is confirmed

    • Lower cardiac output is associated with accelerated cerebral atrophy among older adults who carry the APOE-e4 allele.
    • The protein tau disrupts mitochondria, reversing electron flow in nerve cells.
    • Very high p-tau217 levels may identify cognitively healthy adults who face a substantially greater chance of impairment years later.
    • Depression in older adults is linked to volume loss in the CA23DG hippocampal subfield, independent of Alzheimer's risk factors.

    Still unconfirmed

    • Alzheimer's may scramble the genome's 3D architecture inside brain cells.

    What to watch next

    • Further research on the role of EPS8 in Alzheimer's disease
    • Development of a blood test for Alzheimer's risk
    • Clinical trials for treatments targeting tau and cardiac output
    Sources used for this update (9)
    1. medicalxpress.com — Lower cardiac output predicts faster brain loss in carriers of Alzheimer's disease risk gene
    2. scitechdaily.com — Humans and Mice May Process Smells in Very Similar Ways
    3. scitechdaily.com — Blood Test May Reveal Alzheimer’s Risk Years Before Symptoms
    4. www.newsweek.com — Overlooked Body Function May Predict Faster Alzheimer’s, Study Finds
    5. medicalxpress.com — Alzheimer's-linked tau disrupts mitochondria, reversing electron flow in nerve cells
    6. neurosciencenews.com — Depression Triggers Volume Loss in Memory Brain Areas
    7. neurosciencenews.com — Tau Infiltrates Mitochondria to Drive Alzheimer’s
    8. Phys.org — Atomic view of Alzheimer's disease peptide could inform new drugs
    9. scitechdaily.com — Alzheimer’s May Scramble the Genome’s 3D Architecture Inside Brain Cells
    confidence 90%

  2. Alzheimer's Research Uncovers Multiple Potential Triggers and Risk Factors

    Researchers have identified several potential triggers and risk factors for Alzheimer's disease, including lower cardiac output in carriers of the APOE-e4 allele, buildup of the protein EPS8, tau disrupting mitochondria, and depression in older adults. A blood test may also reveal Alzheimer's risk years before symptoms. Additionally, studies have found that Alzheimer's may scramble the genome's 3D architecture inside brain cells and that humans and mice may process smells in similar ways.

    Why it matters

    Alzheimer's disease is a complex and multifaceted condition, and understanding its causes and risk factors is crucial for developing effective treatments. The research being conducted at institutions such as Vanderbilt Health and the Vanderbilt Memory and Alzheimer's Center is helping to shed light on the underlying mechanisms of the disease. By identifying potential triggers and risk factors, researchers hope to develop new strategies for prevention and treatment.

    What is confirmed

    • Lower cardiac output is associated with accelerated cerebral atrophy among older adults who carry the APOE-e4 allele.
    • Very high p-tau217 levels may identify cognitively healthy adults who face a substantially greater chance of impairment years later.
    • Depression in older adults is linked to volume loss in the CA23DG hippocampal subfield, independent of Alzheimer's risk factors.
    • Tau disrupts mitochondria, reversing electron flow in nerve cells.
    • Alzheimer's may scramble the genome's 3D structure inside brain cells, disrupting genetic controls.

    Still unconfirmed

    • EPS8 builds up during aging, triggering the clumping of toxic proteins that damage neurons and shorten lifespans.

    What to watch next

    • Further studies on the relationship between cardiac output and Alzheimer's disease progression
    • Development of a blood test for Alzheimer's risk based on p-tau217 levels
    • Research on the potential therapeutic applications of targeting tau and mitochondria in Alzheimer's disease
    Sources used for this update (9)
    1. medicalxpress.com — Lower cardiac output predicts faster brain loss in carriers of Alzheimer's disease risk gene
    2. scitechdaily.com — Humans and Mice May Process Smells in Very Similar Ways
    3. scitechdaily.com — Blood Test May Reveal Alzheimer’s Risk Years Before Symptoms
    4. www.newsweek.com — Overlooked Body Function May Predict Faster Alzheimer’s, Study Finds
    5. medicalxpress.com — Alzheimer's-linked tau disrupts mitochondria, reversing electron flow in nerve cells
    6. neurosciencenews.com — Depression Triggers Volume Loss in Memory Brain Areas
    7. neurosciencenews.com — Tau Infiltrates Mitochondria to Drive Alzheimer’s
    8. Phys.org — Atomic view of Alzheimer's disease peptide could inform new drugs
    9. scitechdaily.com — Alzheimer’s May Scramble the Genome’s 3D Architecture Inside Brain Cells
    confidence 80%

  3. Vanderbilt Researchers Identify TAOK-1 Protein Inhibitor for Alzheimer's

    Researchers at Vanderbilt have developed the first selective compound to inhibit TAOK-1, a protein linked to Alzheimer's disease. They also created a second compound that activates the entire TAOK protein family. These tools aim to uncover hidden disease mechanisms and establish new treatment strategies. Separately, scientists using worms discovered that the protein EPS8 builds up during aging, triggering the clumping of toxic proteins that damage neurons and shorten lifespans. Reducing EPS8 activity was found to preserve nerve function and prevent these harmful aggregates.

    Why it matters

    Alzheimer's research traditionally focuses on beta-amyloid plaques and neurofibrillary tangles. New findings regarding TAOK-1 and EPS8 suggest different molecular triggers and pathways for neurodegeneration. These discoveries may expand the range of therapeutic targets beyond established markers.

    What is confirmed

    • Vanderbilt researchers created the first selective compound designed to inhibit TAOK-1, a protein connected to Alzheimer's disease.
    • A second compound was discovered that activates the entire TAOK protein family.
    • In worms, the protein EPS8 builds up with age and triggers signaling that encourages toxic proteins to clump together.
    • Reducing EPS8 activity prevented harmful aggregates and preserved nerve function in worms.

    What to watch next

    • Testing of TAOK-1 inhibitors in human clinical trials
    • Verification of EPS8 protein triggers in human brain tissue
    Sources used for this update (7)
    1. www.sciencefocus.com — 'We have no freaking clue' what weight-loss drugs are doing to your brain, warns Cambridge professor
    2. golfweek-eu.usatoday.com — Most Floridians have 'unhealthy' weight. What diets will eliminate it?
    3. consent.yahoo.com — Can MMA Fighters Taking Psychedelics Unlock the Future of Brain Health? These Researchers Think So.
    4. www.sciencedaily.com — Scientists may have found aging’s hidden trigger for brain disease
    5. www.sciencedaily.com — Two new compounds could reveal hidden drivers of Alzheimer’s disease
    6. www.news-medical.net — How Tau is transforming the future of Alzheimer’s diagnosis and treatment
    7. www.sciencefocus.com — What your penis is trying to tell you about your health
    confidence 100%

  4. Researchers Identify New Proteins and Molecular Switches Linked to Brain Disease

    Vanderbilt researchers developed the first selective compound to inhibit TAOK-1, a protein linked to Alzheimer's disease, and a second compound that activates the TAOK protein family. Separately, scientists identified the protein EPS8 as a molecular switch in worms that triggers toxic protein clumping and neuron damage during aging. These findings, alongside the use of Tau biomarkers for earlier detection, provide new potential targets for treating neurodegenerative conditions like Alzheimer's, ALS, and Huntington's disease.

    Why it matters

    Previous research focused on neurofibrillary tangles, beta-amyloid plaques, and mitochondrial plaques as therapeutic targets. These new discoveries shift focus toward specific protein inhibitors and aging-related molecular triggers. Understanding these mechanisms helps explain why brain vulnerability increases with age.

    What is confirmed

    • Vanderbilt researchers created a selective compound to inhibit the protein TAOK-1.
    • The protein EPS8 builds up with age in worms and triggers signaling that causes toxic proteins to clump and damage neurons.
    • Reducing EPS8 activity in worms preserved nerve function and prevented harmful aggregates.
    • Tau biomarkers are being used to enable earlier detection of Alzheimer's disease.

    Still unconfirmed

    • A second compound that activates the entire TAOK protein family may reveal hidden disease mechanisms.

    What to watch next

    • Clinical trials testing the TAOK-1 inhibitor in humans.
    • Studies confirming if EPS8 functions as a trigger for brain disease in mammals.
    Sources used for this update (7)
    1. www.sciencefocus.com — 'We have no freaking clue' what weight-loss drugs are doing to your brain, warns Cambridge professor
    2. golfweek-eu.usatoday.com — Most Floridians have 'unhealthy' weight. What diets will eliminate it?
    3. consent.yahoo.com — Can MMA Fighters Taking Psychedelics Unlock the Future of Brain Health? These Researchers Think So.
    4. www.sciencedaily.com — Scientists may have found aging’s hidden trigger for brain disease
    5. www.sciencedaily.com — Two new compounds could reveal hidden drivers of Alzheimer’s disease
    6. www.news-medical.net — How Tau is transforming the future of Alzheimer’s diagnosis and treatment
    7. www.sciencefocus.com — What your penis is trying to tell you about your health
    confidence 100%

  5. University of Minnesota Researchers Identify New Mitochondrial Plaques in Alzheimer's

    A University of Minnesota research team has discovered a type of mitochondrial plaque that may serve as a new therapeutic target for Alzheimer's disease. This finding, published in Nature Neuroscience, adds to the known hallmarks of the disorder, which include neurofibrillary tangles and beta-amyloid plaques. While these established markers damage and kill brain cells over time, the identification of mitochondrial plaques offers a different potential pathway for treating the neurodegenerative condition.

    Why it matters

    Alzheimer's is a global neurodegenerative disorder. Previous reports highlighted the use of blood tests to identify early markers more easily than brain scans or spinal taps. Understanding the specific triggers and plaques of the disease helps scientists develop drugs to slow its progression.

    What is confirmed

    • Two hallmarks of Alzheimer's disease are neurofibrillary tangles and beta-amyloid plaques.
    • A University of Minnesota research team identified a type of plaque that represents a potential new therapeutic target for Alzheimer's disease.

    Still unconfirmed

    • A protein associated with Alzheimer's disease may also identify brain conditions linked to head trauma in contact sports.

    What to watch next

    • Clinical trials testing therapies targeting mitochondrial plaques
    • Peer review or replication of the University of Minnesota findings in other cohorts
    Sources used for this update (7)
    1. medicalxpress.com — Inflammation may drive Dravet syndrome, offering a potential new treatment target
    2. www.news-medical.net — Steam Therapy Benefits: Potential Effects on Heart, Lung and Skin Health
    3. consent.yahoo.com — 86 Random, But Fascinating Things You Probably Didn't Know About The World Until Today (New Pics)
    4. www.sciencenews.org — To detect CTE while alive, a test for another brain disease may help
    5. www.rfi.fr — Where you live could decide how well you breathe, French study finds
    6. www.fredhutch.org — Science-backed solutions for dealing with wildfire smoke, pollutants
    7. medicalxpress.com — Newly identified mitochondrial plaques provide potential therapeutic target for Alzheimer's disease
    confidence 100%

  6. Blood Tests Improve Early Alzheimer's Detection

    New blood tests identify early markers of Alzheimer's disease more easily than spinal taps or brain scans. Early detection may increase the effectiveness of drugs designed to slow the disease. Research also shows that genetic risk alone does not determine memory retention or disease onset.

    What's confirmed:

    • Blood tests for early Alzheimer's markers are less invasive than spinal taps or brain scans.
    • Early identification of Alzheimer's may increase the benefit of drugs that slow progression.

    Still unconfirmed:

    • A review article published April 21, 2026, in Frontiers in Nutrition links ultra-processed foods to biological aging.
    Sources used for this update (5)
    1. Can Alzheimer's genes predict who becomes a SuperAger?
    2. Parents to get benefits top-up to encourage their children into apprenticeships
    3. Tests for early markers of Alzheimer's can be effective for understudied population at high risk
    4. Man who carries a gene mutation for early-onset Alzheimer’s has somehow dodged the disease
    5. This Common Food Habit Is Quietly Stealing Years From Your Life
    confidence 90%

  7. Common Brain Protein Linked to Alzheimer's Spread

    Researchers identified a brain protein that transports toxic Tau proteins from damaged neurons to healthy ones. Blocking these protein packages could potentially slow the progression of the disease. This mechanism was observed in mice.

    What's confirmed:

    • The Arc protein helps spread toxic molecules from sick brain cells to healthy ones in mice.
    • A common brain protein carries toxic Tau proteins from damaged neurons into healthy cells.

    Still unconfirmed:

    • Gut bacteria may link to brain inflammation and cognitive decline.
    • An ancient grain shows early lab promise against a key Alzheimer's protein.
    Sources used for this update (5)
    1. How a Brain Messenger Protein Drives Progression of Alzheimer’s Disease
    2. This Genetic Variant May Make You More Vulnerable To Alcohol-Related Brain...
    3. Ancient grain shows early lab promise against a key Alzheimer's protein
    4. Scientists may have finally found how Alzheimer's ... - ScienceDaily
    5. Gut Health and Alzheimer's: What the Science Says
    confidence 90%

  8. UCR Researchers Identify Potential New Alzheimer's Trigger

    Researchers at the University of California, Riverside suggest Alzheimer's begins inside neurons rather than with plaques. The process involves amyloid beta interfering with tau proteins. An experimental compound has demonstrated the ability to block this process in mice.

    What's confirmed:

    • Researchers at the University of California, Riverside suggest Alzheimer's may start inside nerve cells rather than with plaques.
    • Amyloid beta appears to interfere with tau proteins that maintain neuron function.
    • An experimental compound slowed nerve cell loss and reduced Alzheimer's-related changes in mice.

    Still unconfirmed:

    • The experimental drug NU-9 blocks early damage and reduces inflammation in mice.
    • Removing the IDOL enzyme from neurons reduces amyloid plaques and improves brain communication.
    • The STING protein acts as a molecular switch that fuels brain inflammation.
    • Columbia research indicates tau filaments may be stopped at their source.
    Sources used for this update (8)
    1. Scientists May Have Found What Really Triggers Alzheimer’s Disease
    2. New trigger for Alzheimer's disease may have been found
    3. Scientists found a new Alzheimer's trigger and a drug that stops it
    4. A new drug could stop Alzheimer's before memory loss begins
    5. New Study Finds Clues of Alzheimer's Beginnings
    6. Scientists found a hidden Alzheimer's trigger and shut it down
    7. Scientists Found a New Alzheimer's Trigger, And a Drug to Slow It in ...
    8. Scientists found the hidden switch fueling alzheimer's brain ...
    confidence 90%

  9. Researchers Propose New Molecular Trigger for Alzheimer's Disease

    Scientists at the University of California, Riverside suggest Alzheimer's may begin deep inside neurons rather than with plaques. New research indicates amyloid beta might hijack tau within these neurons. A candidate drug has shown success in blocking this neurodegenerative cascade during preclinical studies.

    What's confirmed:

    • Research suggests amyloid beta may hijack tau inside neurons.
    • Evidence indicates the earliest changes of Alzheimer's may start deep inside neurons.
    • Researchers at the University of California, Riverside proposed a new explanation for how the disease begins.

    Still unconfirmed:

    • A candidate drug blocks the neurodegenerative cascade in preclinical studies.
    • A new protein discovered by St. Jude Children's Research Hospital protects the brain against Alzheimer's.
    • University Hospitals and Case Western Reserve University identified a molecular cause of age-related cognitive decline.
    Sources used for this update (12)
    1. Alzheimer's News -- ScienceDaily
    2. New Trigger for Alzheimer’s Disease May Have Been Found
    3. Scientists May Have Found What Really Triggers Alzheimer’s Disease
    4. From Lab to Life: Alzheimer’s Breakthrough
    5. New Trigger for Alzheimer's Disease May Have Been Found
    6. Alzheimer's Breakthrough: Research Points to Protein Hijack as Key ...
    7. New trigger for Alzheimer's disease may have been found
    8. New Alzheimer's Trigger Identified — Drug Blocks It in Early Tests
    9. Possible Alzheimer's Trigger Identified by Scientists
    10. Scientists May Have Found What Really Triggers - One News Page
    11. Molecular cause of age-related cognitive decline identified
    12. Researchers discover new protein that protects the brain against Alzheimer’s dis...
    confidence 80%